Binocular Amblyopia Treatment
Launched by RETINA FOUNDATION OF THE SOUTHWEST · Sep 18, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to treat amblyopia, a common vision problem often referred to as "lazy eye." The goal is to see if special binocular treatments, which encourage both eyes to work together, can help children recover their vision more completely and steadily. The study is currently recruiting participants, particularly children aged 4 to 10 years who have specific types of amblyopia. To qualify, children should have a noticeable difference in vision between their two eyes, with the weaker eye needing to have a certain level of clarity when corrected with glasses.
If a child is eligible to participate, they will not be using traditional patching treatment for the 12 weeks of the study. Instead, they will engage in fun binocular games designed to help improve their vision. Before joining, a parent or guardian must give their consent, and the child must be able to understand and participate in these games. This trial offers an exciting opportunity for children to potentially improve their vision in a supportive and engaging way!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 4-10 y
- • male and female
- • strabismic, anisometropic, or combined mechanism amblyopia
- • amblyopic eye best-corrected visual acuity 0.3-0.8 logMAR
- • fellow eye best-corrected visual acuity ≤0.1 logMAR
- • interocular visual acuity difference ≥0.3 logMAR
- • wearing glasses (if needed) for 8 weeks or no change visual acuity with glasses at 2 visits
- • 4 weeks apart.
- • child's ophthalmologist and family must be willing to forgo patching treatment during the 12-week study period
- • parent's informed consent
- • child must demonstrate understanding and ability to play binocular games
- Exclusion Criteria:
- • prematurity ≥8 weeks
- • coexisting ocular or systemic disease
- • developmental delay
- • strabismus \>5pd
- • any binocular amblyopia treatment in the past 3 months
About Retina Foundation Of The Southwest
The Retina Foundation of the Southwest is a leading clinical research organization dedicated to advancing the understanding and treatment of retinal diseases. With a focus on innovative therapies and cutting-edge research, the foundation collaborates with top-tier medical institutions and specialists to conduct rigorous clinical trials aimed at improving patient outcomes. Committed to excellence in patient care and scientific discovery, the Retina Foundation of the Southwest is at the forefront of developing novel interventions for conditions such as macular degeneration, diabetic retinopathy, and other vision-threatening disorders. Through its comprehensive approach, the foundation strives to enhance the quality of life for individuals affected by retinal diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials